Biodegradable microspheres of poly(D,L-lactide) containing progesterone

Authors

  • D CHIAPPETTA Departamento de Tecnología Farmacéutica
  • MJ LEGASPI Departamento de Tecnología Farmacéutica
  • V NISELMAN Departamento de Fisicomatemática, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires
  • R PASQUALI Departamento de Tecnología Farmacéutica
  • E GERGIC Departamento de Tecnología Farmacéutica
  • AC RODRÍGUEZ LLIMÓS Departamento de Tecnología Farmacéutica
  • C BREGNI Departamento de Tecnología Farmacéutica

Keywords:

Biodegradable microspheres, Factorial design, D, L-PLA, Progesterone, Sustained release

Abstract

Microspheres of poly(D,L-lactide) containing progesterone were prepared by the solvent evaporationmethod using a simple oil water emulsion. 23 factorial design was used to determine the effect of threeindependent variables (amount of drug, amount of polymer and concentration of polyvinyl alcohol) overthe dependent variables (drug content and particle size). The three independent variables influencedsignificantly over the percentage drug encapsulated. On the other hand, in the particle size case, thevariables which produced a significantly influence were the polyvinyl alcohol concentration and theamount of polymer. The in vitro release studies have shown that according to the particle size, it canbe obtained formulations which are able to release progesterone in a few days or a sustained releaseamong 28 days. The physical state of drug has been examined by differential scanning calorimetric. Thestudies indicate that exists a physicochemical interaction between the progesterone and the polymer.

Downloads

Download data is not yet available.

References

Phemister DA, Laurent S, Harrison FNH. Use of norplant contraceptive implants in the immediate postpartum period: Safety

and tolerance. American Journal of Obstetrics and Gynecology 1995; 172 (1): 175-179.

Elchalal U, Abramov Y. Uterine biology and the intrauterine device. Advanced Drug Delivery Reviews 1995; 17: 151-164.

Singh M, O´Hagan D. The preparation and characterization of polymeric antigen delivery systems for oral administration.

Advanced Drug Delivery Reviews 1998; 34: 285-304.

Rosilio V, Benoit JP, Deyme M, Thies C, Madelmont G. A physicochemical study of the morphology of progesteroneloaded

microspheres fabricated from poly(D,L-lactide-co-glycolide). Journal of Biomedical Materials Research 1991; 25(5): 667-682.

Izumikawa S, Yoshioka S, Aso Y, Takeda Y. Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. J Control Release 1991; 15(2): 133-140.

Aso Y, Yoshioka S, Li Wan Po A, Terao T. Effect of temperature on mechanisms of drug release and matrix degradation of poly(D,L-lactide) microspheres. J Control Release 1994; 31: 33-39.

Buntner B, Nowak M, Kasperczyk J, Ryba M, Grieb P, Walski M, Dobrzyñski P, Bero M. The application of microspheres from the copolymers of lactide and å-caprolactone to the controlled release of steroids. J Control Release 1998; 56(1-3): 159-167.

Yang Q, Owusu-Ababio G. Biodegradable Progesterone Microsphere Delivery System for Osteoporosis Therapy. Drug Dev Ind Pharm 2000; 26(1): 61-70.

Ikwueme S, Taylor KMG, Craig DQM, Saklatvala R. The preparation and evaluation of progesterone-loaded poly(d,llactide) microspheres. J Pharm Pharmacol 2000; 52(Supplement): 17.

Sah H. Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres. Int J Pharm 2000; 195: 103-113.

Han MJ, Nam ST, Lee JH. Effect of coagulating conditions on the morphology of membrane and drug being impregnated. Polymer 2001; 25(2): 151-159.

Rathbone MJ, Bunt CR, Ogle CR, Burggraaf S, Macmillan KL, Pickering K. Development of an injection molded poly(åcaprolactone) intravaginal insert for the delivery of progesterone to cattle. J Control Release 2002; 85: 61-71.

Danckwerts MP, van der Watt JG. The effect of processing variables on the compression properties of controlled release core-in-cup compressed tablets from a new adjustable punch. Int J Pharm 1995; 123(1): 85-94.

Ngo TH, Vertommen J, Kinget R. Formulation of artemisinin tablets. Int J Pharm 1997; 146(2): 271-274.

Ceschel GC, Maffei P, Badiello R. Optimization of a Tablet Containing Chlorthalidone. Drug Dev Ind Pharm 1999; 25 (11): 1167-1176.

Jones DS, Pearce KJ. An investigation of the effects of some process variables on the microencapsulation of propranolol

hydrochloride by the solvent evaporation method. Int J Pharm 1995; 118: 199-205.

Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Cont Release 1998; 51: 115-122.

Elkheshen SA, Badawi SS, Badawi AA. Optimization of a Reconstitutable Suspension of Rifampicin Using 24 Factorial

Design. Drug Dev Ind Pharm 1996; 22 (7): 623-630.

Vila Jato JL. Tecnología Farmacéutica – Aspectos fundamentales de los sistemas farmacéuticos y operaciones básicas, Editorial Síntesis, Madrid; 1997, pp. 75-142.

Reynolds JEF. Martindale-The Extra Pharmacopoeia Sex Hormones. 31º edition, The Royal Pharmaceutical Society, Londres; 1996, pp. 1505.

Sáez V, Hernáez E, Sanz Angulo L, Katime I. Liberación controlada de fármacos. Micropartículas. Revista Iberoamericana de Polímeros 2004; 5 (2): 87-101.

Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123-133.

Jun HW, Lai JW. Preparation and in vitro dissolution tests of egg albumin microcapsules of nitrofurantoin. Int J Pharm 1983; 16 (1): 65-77.

Shukla AJ, Price JC. Effect of Drug (Core) Particle Size on the Dissolution of Theophylline from Microspheres Made from Low Molecular Weight Cellulose Acetate Propionate. Pharm Res 1989; 6 (5): 418-421.

Shukla AJ, Price JC. Effect of Drug Loading and Molecular Weight of Cellulose Acetate Propionate on the Release Characteristics of Theophylline Microspheres. Pharm Res 1991; 8 (11): 1396-1400.

Dash AK. Determination of the physical state of drug in microcapsule and microsphere formulations. J Microencapsulation

; 14 (1): 101-112.

Kibbe AH. Handbook of pharmaceutical excipients. 3rd edition. American Pharmaceutical Association, Washington; 2000, pp. 13-17.

Published

2005-09-20

How to Cite

1.
CHIAPPETTA D, LEGASPI M, NISELMAN V, PASQUALI R, GERGIC E, RODRÍGUEZ LLIMÓS A, BREGNI C. Biodegradable microspheres of poly(D,L-lactide) containing progesterone. Ars Pharm [Internet]. 2005 Sep. 20 [cited 2024 Nov. 20];46(4):383-98. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/5094

Issue

Section

Original Articles